Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07301892

Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis

Impact of Generative Artificial Intelligence on Diagnosing Rheumatoid Arthritis Complications

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Generative AI (GenAI) based on large language models (LLMs) is expected to improve the diagnosis and treatment of autoimmune diseases. We are studying how GenAI may affect the diagnosis of various complications of rheumatoid arthritis (RA). In a retrospective study using RA patients' EHR records, we will quantify physician adoption of GenAI predictions for RA complications and co-existing diseases. In a prospective observational study, we will assess the feasibility of using GenAI predictions as additional clinical information to help physicians make more complete diagnoses of RA complications and co-existing diseases, including complex, uncommon, or rare conditions.

Conditions

Interventions

TypeNameDescription
OTHERGenerative AI prediction report for RA complicationsGenerative AI based on multiple large language models (LLMs) is used to predict potential complications and co-existing diseases in patients with rheumatoid arthritis using EHR data available at admission. Physicians use these AI predictions as additional information to adjust their diagnostic plans during differential diagnosis. The impact of this intervention on the final diagnoses at discharge will be measured. Before the prospective study, the adoptability of the generative AI prediction reports will be validated using EHR records from retrospective RA patients.

Timeline

Start date
2025-10-01
Primary completion
2026-02-01
Completion
2026-06-01
First posted
2025-12-24
Last updated
2025-12-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07301892. Inclusion in this directory is not an endorsement.